Author Archive for: Jenny
Entries by Jenny
MPN updates for 2020 – video from Drs Ruben Mesa and Robyn Scherber
Drs Mesa and Scherber, haematologists from the Mays Cancer Centre in the US, discuss the latest findings from the American Society of Hematology meeting in December 2019, as well as the latest updates regarding new treatments for MPNs. They also discuss quality of life issues for MPN patients. WATCH VIDEO
Easy new way for Australians to register to become a bone marrow donor
An exciting new change has occurred to the way Australians can register to become blood stem cell donors. A simple cheek swab is now all you need to do to register through the Australian Bone Marrow Donor Registry’s ‘Strength to Give’ campaign. For a small number of MPN patients, the only possibility of prolonging survival […]
Leukaemia Foundation’s ‘Light the Night’ – October events across Australia
What is Light The Night? Light the Night is the Leukaemia Foundation’s beautiful evening lantern walk, where Australians come together and transform the darkness into a sea of glowing light to give hope to all those impacted by blood cancer. It’s your night to walk beside those facing their own blood cancer journey, and to remember […]
Call for PBAC submissions to make Jakavi available for PV patients
Novartis is proposing to the Australian Pharmaceutical Benefits Advisory Committee that Jakavi (ruxolitinib) be made available on the PBS for patients with polycythemia vera (PV). Currently Jakavi is on the PBS for patients with myelofibrosis in certain circumstances. The use of Jakavi by Novartis is proposed for PV patients in certain circumstances – that is, […]
New class of drugs being developed for treatment of polycythaemia vera
An update on the progress with these newly developed drugs is provided by Associate Professor David Ross, Consultant Haematologist at Royal Adelaide Hospital and Flinders Medical Centre, Adelaide ———————————————————————————— Treatment options for polycythaemia vera (PV) are limited at present. Hydroxyurea, a mild chemotherapy tablet, is the most widely used drug treatment in Australia, although the use […]
Leukaemia Foundation
The MPN Alliance Australia works in partnership with the Leukaemia Foundation, who manage the dedicated MPN Fund and provide governance.